Trial
NCT02322606
A Phase 1, Single and Multiple Dose Study of TAK-137
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Healthy Japanese Adult Male
Intervention
TAK-137 5 mg tablet, TAK-137 placebo tablet
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-26